"How can I reduce HAI
rates with limited staff
and cost constraints?"

Help is here. Start with a no cost assessment.

* These fields are required.

Nasal Colonization Risk Mitigation Programs

Nozin, leaders in developing and implementing MRSA / MSSA risk mitigation programs, introduces NOVASM. A proprietary suite of tools and services, NOVASM programs are guided by experienced consultants and proven to reduce infection risks while improving patient care.

Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) infections are a major component of total healthcare-associated infections (HAIs).

Patients who are colonized with MRSA in the nares are 14 to 20 times more likely to acquire MRSA infection than non-carriers.

NOVASM colonization risk mitigation programs reduce colonization, which reduces infection risk.

Facilities that have adopted the NOVA programs approach are reporting significant outcomes such as:


reduction in MRSA bacteremia hospital-wide2

Advent Health North Pinellas, FL


reduction in total hip and knee SSI2

Wellstar Cobb Hospital, GA


decline in MRSA bacteremia2

Jackson Health System, FL

Visit nozin.com/clinical-outcomes for more data.

How Nozin NOVASM Programs Work

Nozin NOVASM programs are a proprietary suite of analytical tools and services guided by experienced consultants. Built on shared knowledge from hundreds of facility implementations, NOVASM programs are proven to reduce infection risks while improving patient care.

We know that making the change from traditional strategies can be a challenge. Here’s what you can expect when you partner with Nozin NOVASM .

Comprehensive Risk Assessment

  • Detail the extent of colonization in your facility
  • Determine the risk colonization represents
  • Gauge the impact on your facility and potential improvement
  • Analyze efficacy of current protocols

Customized Programs

  • Help design new colonization risk mitigation strategy
  • Define your desired improvement goals
  • Collaboratively design implementation plan to achieve your goals


  • Prepare for and execute a successful implementation and compliance maintenance program
  • Continuous support by the Nozin NOVA team to ensure success


More outcomes data published or presented than for any other nasal antiseptic

15-year safety record

Millions of users

Fast, easy, pleasant application – preferred by staff and patients

Patented Nozaseptin® formula:

  • Kills 99.99% of germs
  • 12-hour persistence

Proprietary Popswab® delivery system

More daily decolonization outcomes data

The right tool for nasal colonization risk mitigation programs

Rechargeable for second nostril application

Schedule your NOVASM Assessment

Facilities that have implemented Nozin NOVASM programs have shown up to $1.4 million annual cost savings2 and up to 60% reduction in PPE use2. Take the first step today.

Learn More

Evidence counts. See why we’re the leader in daily nasal decolonization.

Download White Paper